If you are pregnant or planning a pregnancy and searching for the acyclovir cream pregnancy category, the key point is that the UK does not use a lettered pregnancy category system for aciclovir cream. Instead, UK guidance looks at the available safety data, and current information from UKTIS/Bumps does not show an increased risk of birth defects with aciclovir use in pregnancy.
If you are dealing with a cold sore, two separate questions tend to get mixed together: is aciclovir itself safe to use, and could a cold sore affect your baby or newborn?
This guide answers both, using UK pregnancy safety data rather than the US-style pregnancy category system that is sometimes quoted on UK websites but does not actually apply here. It also explains the difference between cream and tablets, how aciclovir compares with valaciclovir (the tablet form that converts to aciclovir in the body), what to know about breastfeeding, and the practical steps that help reduce the risk of neonatal herpes after birth.
Aciclovir is available as a cream and tablets, while valaciclovir is available as tablets, including under the brand name Valtrex. Cream is generally used for cold sores on the lips and surrounding skin. Tablets may be used for more extensive or recurrent herpes infections, genital herpes or shingles, depending on the clinical situation.
Is Aciclovir Safe in Pregnancy? What the Data Actually Shows About Birth Defects
There is no lettered "pregnancy category" system used by UK medicines regulators. Some non-UK sources use letter-based classifications for aciclovir, but these do not form part of UK medicines guidance. If you have seen "aciclovir cream pregnancy category B" stated as fact, that claim does not reflect how UK medicines information actually works.
What UK guidance relies on instead is safety data gathered by the UK Teratology Information Service (UKTIS), published in patient-facing form as Bumps (Best Use of Medicines in Pregnancy).
Large observational studies and pregnancy registries involving aciclovir exposure have not found an increased risk of congenital malformations or preterm delivery associated with the medicine itself.
The background risk of a birth defect exists in every pregnancy, whether or not medicines are taken.
Genital herpes infection itself, rather than its treatment, may be associated with pregnancy complications, and treatment decisions are made by the antenatal team based on the clinical situation.
Aciclovir Cream Specifically
Aciclovir cream is applied directly to the skin. Because only a small amount is absorbed systemically, topical aciclovir may be considered for a straightforward cold sore when cream is an appropriate treatment for the location and severity of the outbreak.
Product information provides instructions on how often and for how long aciclovir cream should be used. During pregnancy, confirm the appropriate product and treatment instructions with your pharmacist, midwife, GP or prescriber.
Aciclovir cream is intended for use on the lips and surrounding skin only. It is not intended for use inside the nose or mouth, near the eyes, or on other internal or mucous membrane surfaces, and this applies regardless of pregnancy.
Aciclovir and Valaciclovir Tablets for Genital Herpes in Pregnancy
Tablets may be considered when systemic treatment is clinically indicated, including for genital herpes, shingles and some more significant or recurrent herpes infections.
As with the cream, this is a decision made with your midwife, GP or prescriber rather than something to self-select. Two broad situations come up in UK guidance: aciclovir is prescribed for primary genital herpes infections in pregnancy, and later suppressive treatment may also be advised.
| Situation | General UK clinical approach (background only, not a personal instruction) |
|---|---|
| A first episode of genital herpes in the second or third trimester | Antiviral treatment may be recommended for a first episode of genital herpes during pregnancy. The choice of medicine and regimen is determined by the antenatal team. |
| Suppressive therapy from around 36 weeks, for those with a history of genital herpes | Suppressive antiviral treatment from around 36 weeks may be recommended for women with recurrent genital herpes to reduce the likelihood of lesions or viral shedding around delivery. |
This table describes general UK approaches, not a recommendation for any individual. Do not stop the medication altogether or change treatment without advice from a healthcare provider. Your own antenatal team will confirm what, if anything, applies to you, particularly if you have a history of genital herpes rather than only ever having had lip cold sores.
Chickenpox Is a Different Situation
It is worth being clear that chickenpox (varicella) in pregnancy is a distinct condition from herpes simplex, even though chickenpox and shingles are infections caused by the herpes virus family, and it is managed through a different pathway.
Chickenpox exposure or infection during pregnancy is usually assessed via specialist or fetal medicine referral.
Some cases may require antiviral treatment, and varicella-zoster immunoglobulin (VZIG) may be considered after certain exposures depending on timing and immunity status.
If you develop chickenpox, or are exposed to it, while pregnant, contact your midwife or GP promptly rather than assuming it is treated the same way as a cold sore. Severe or disseminated infection can be life threatening in pregnancy, so an untreated illness should not be assumed to be minor.
Cold Sores, Pregnancy and Your Baby: What the Real Risk Is
This is the point most commonly muddled in generic content, so it is worth separating clearly. A typical lip cold sore is not generally considered a route of transmission to the unborn baby during pregnancy.
The condition that genuinely matters for a newborn is neonatal herpes, and it has two quite different routes. That said, the question is not only medicine safety: untreated infections in pregnancy can also lead to complications, so the real balance is treatment risk versus the risk of leaving an infection unmanaged.
| Route | What it involves |
|---|---|
| Around birth (genital herpes) | Risk relates to genital herpes, particularly a first episode acquired in the third trimester, and exposure during a vaginal delivery. This is why suppressive therapy from around 36 weeks is often discussed for those with a history of recurrent genital herpes, in part to reduce viral shedding near delivery. |
| After birth (cold sore transmission) | A newborn can catch HSV if kissed by someone with an active cold sore, or touched by someone who has recently touched a cold sore without washing their hands. This route is separate from pregnancy itself and applies to anyone in contact with the baby, not only the mother. |
A first episode of genital herpes during pregnancy can be more clinically significant than a recurrent episode, particularly when acquired later in pregnancy.
Neonatal herpes is rare (estimated at roughly 7 in every 100,000 births in the UK) but can be serious, and babies are most vulnerable in approximately the first 4 to 6 weeks of life, when their immune system is still immature. NHS guidance on reducing the risk after birth includes: everyone washing their hands before handling the baby, discouraging anyone who is not a close family member or carer from kissing the baby, kissing the baby on the top of the head rather than near the mouth, nose or eyes, and anyone with a current cold sore, or a recent history of one, not kissing the baby at all. If you or a partner has a herpes blister on the breast, avoid feeding from that breast, or using expressed milk from it, until it has healed.
These practical precautions are particularly relevant during the first weeks after birth, when a newborn is more vulnerable to serious HSV infection.
Aciclovir and Breastfeeding
Aciclovir is generally considered compatible with breastfeeding. As an antiviral medication, studies indicate that only small amounts of aciclovir pass into breast milk, and it is generally considered compatible with breastfeeding. The main practical exception is a herpes blister located directly on the breast: avoid feeding from that breast, or using milk expressed from it, until the lesion has fully healed, both to protect the baby from direct contact and because of the transmission risk described above. If acyclovir cream or ointment is used on skin near the breast, clean the area before feeding. For breastfeeding questions, speak to a healthcare provider.
Systemic Prenatal Acyclovir Exposure Before or Around Conception
Aciclovir use before conception is not expected to increase the risk of adverse pregnancy outcomes based on available evidence. There are limited data on effects on fertility, but available human data have not identified a clear adverse effect.
Medical Disclaimer
This guide is provided for general information only and does not constitute medical advice. It is not a substitute for professional medical care or consultation with a qualified healthcare professional, midwife, or your antenatal team. Aciclovir and valaciclovir are prescription medicines used to treat infections such as herpes, and treatment suitability, strength and duration depend on an individual clinical assessment. This article does not provide dosing instructions. Always tell your midwife, GP or pharmacist that you are pregnant or breastfeeding before starting or continuing any medicine, and do not start, stop or change treatment without advice from your healthcare provider. If you have a history of genital herpes, or develop it for the first time during pregnancy, discuss this with your antenatal team, since it is managed differently from a lip cold sore. Seek urgent medical advice if your newborn baby develops symptoms such as unusual sleepiness, poor feeding, blisters, a high or low temperature, or breathing difficulties.
